Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Bech Pharma Consulting AB
AB
Active
Org 5591979355
Pirgatan 13, 374 35
Karlshamn
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 7 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Bech Pharma Consulting AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
458
7
6
9
7
Staff expenses
—
—
—
−0
−0
EBITDA
420
−16
−13
−9
−11
Depreciation & amort.
−0
−0
—
—
—
EBIT
420
−16
−13
−9
−11
Net financials
—
—
−0
5
0
Profit before tax
315
2
2
3
2
Tax
−65
−1
−2
−2
−1
Net profit
250
1
0
1
0
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 181
1 065
1 014
1 009
996
Equity
738
740
740
741
741
Long-term debt
0
0
—
—
—
Short-term debt
153
54
17
18
18
Total debt
153
54
17
18
18
Financial ratios
5-year trend
EBITDA margin
-153.3%
This company
15.8%
Market median
-1070% vs market
2021
2025
Equity ratio
74.4%
This company
38.2%
Market median
+95% vs market
2021
2025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2021
2025
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
2021
2025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
2021
2025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Bech Pharma Consulting AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
